Article may be outdated

This article is 23 days old. Some details may have changed since publication.

Headlinne
Sign inGet Headlinne
The Hindu·3 min read·medium

Generics maker Laurus Lab’s net profit more than doubles in Q1 on strong CDMO business growth

T
The Hindu Bureau
Generics maker Laurus Lab’s net profit more than doubles in Q1 on strong CDMO business growth
✦AI Summary

Laurus Labs reported a significant increase in net profit for the June quarter, with revenue more than doubling year-on-year. The growth was primarily driven by a 67% surge in the company's CDMO business and strong performance in its generics division.

Why it mattersUnlock →

Generic drugmaker Laurus Labs’ consolidated net profit more than doubled year-on-year (YoY) to ₹361.99 crore for the June quarter, driven by a 29% jump in revenue.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
businesshealth
Political bias analysisUnlock →
Read originalGet full access
✦

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in